Protective effects specific platelet-activating factor receptor antagonists experimental glomerulonephritis present study hypothesis production platelet-activating factor PAF renal hemodynamic alterations impaired glomerular permselectivity heterologous phase nephrotoxic serum nephritis Intravenous administration nephrotoxic gamma globulin normal rats rapid decline glomerular filtration rate min effective renal plasma flow rate fractional excretion protein Pretreatment specific PAF receptor antagonists WEB impairment glomerular filtration rate effective renal plasma flow rate nephrotoxic globulin Filtration rate b.wt min administration nephrotoxic globulin b.wt rats WEB b.wt rats WEB decline effective renal plasma flow rate min administration nephrotoxic globulin b.wt rats WEB NS b.wt rats WEB 